Back to search
FDAFDA · Food and drugs·Recall number F-0467-2022

Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3

Published January 19, 2022 · Recall initiated: November 9, 2021

Summary

FDA records food Class I recall F-0467-2022, published January 19, 2022 and initiated November 9, 2021. Recalling firm: NutraCap Labs LLC; Status: Terminated; Reported quantity: 80,169 various bottles and jars; Lot: LOT #2110060 EXP DATE 10/2023 LOT #2108169 EXP DATE 08/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

During an FDA investigation the firm was notified that the product contains undeclared milk.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NutraCap Labs LLC
Distributor
Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, LA, MD, MN, NC, NJ, NV, NY, OH, OR, SC, TN, TX, VA & WA.
Lot
LOT #2110060 EXP DATE 10/2023 LOT #2108169 EXP DATE 08/2023
Risk classification
Class I
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3 recalled?

Yes. FDA published recall F-0467-2022 on January 19, 2022. Reported hazard: During an FDA investigation the firm was notified that the product contains undeclared milk.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release